Based on the ALPHAHELIX MOL.DIAGN. SK1 stock forecast from 0 analysts, the average analyst target price for ALPHAHELIX MOL.DIAGN. SK1 is not available over the next 12 months. ALPHAHELIX MOL.DIAGN. SK1’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of ALPHAHELIX MOL.DIAGN. SK1 is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, ALPHAHELIX MOL.DIAGN. SK1’s stock price was EUR 0.01. ALPHAHELIX MOL.DIAGN. SK1’s stock price has changed by -54.84% over the past week, -56.25% over the past month and -76.51% over the last year.
No recent analyst target price found for ALPHAHELIX MOL.DIAGN. SK1
No recent average analyst rating found for ALPHAHELIX MOL.DIAGN. SK1
Company Overview ALPHAHELIX MOL.DIAGN. SK1
Level Bio AB (publ) designs, develops, and distributes diagnostics products in the Nordic region and internationally. The company distributes equipment; consumables and reagents for molecular biology; and research and diagnostic products in Sweden and the Nordics. It also develops, produces, and sells products for genetic fetal diagnostics, as well as genetic miscarriage and infertility diagnostics products. In addition, the company engages in the development of products for congenital heart defect. Its product portfolio includes Rob, an automated 96/384 qPCR setup; BugScreener, a system for screening methicillin resistant staphylococcus aures; and aAmp, a thermal cycler that utilizes SuperConvection technology, which enables accurate PCR assays. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024. Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden. Read Less
Level Bio AB (publ) designs, develops, and distributes diagnostics products in the Nordic region and internationally. The company distributes equipment; consumables and reagents for molecular biology; and research and diagnostic products in Sweden and the Nordics. It also develop...Read More
Frequently Asked Questions About ALPHAHELIX MOL.DIAGN. SK1 (4MB:F) Stock
Stock Target Advisor's fundamental analysis for ALPHAHELIX MOL.DIAGN. SK1's stock is Very Bearish.
Unfortunately we do not have enough data on 4MB:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4MB:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4MB:F's stock to indicate if its overvalued.
The last closing price of 4MB:F's stock was EUR 0.01.
The most recent market capitalization for 4MB:F is EUR 1.78M.
Unfortunately we do not have enough analyst data on 4MB:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains ALPHAHELIX MOL.DIAGN. SK1's stock.
As per our most recent records ALPHAHELIX MOL.DIAGN. SK1 has 13 Employees.
ALPHAHELIX MOL.DIAGN. SK1's registered address is Västra Finnbodavägen 4B, Stockholm, Sweden, 131 30.
You can get more information about it from ALPHAHELIX MOL.DIAGN. SK1's website at https://levelbio.se.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About ALPHAHELIX MOL.DIAGN. SK1 (4MB:F) Stock
Stock Target Advisor's fundamental analysis for ALPHAHELIX MOL.DIAGN. SK1's stock is Very Bearish.
Unfortunately we do not have enough data on 4MB:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4MB:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4MB:F's stock to indicate if its overvalued.
The last closing price of 4MB:F's stock was EUR 0.01.
The most recent market capitalization for 4MB:F is EUR 1.78M.
Unfortunately we do not have enough analyst data on 4MB:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains ALPHAHELIX MOL.DIAGN. SK1's stock.
As per our most recent records ALPHAHELIX MOL.DIAGN. SK1 has 13 Employees.
ALPHAHELIX MOL.DIAGN. SK1's registered address is Västra Finnbodavägen 4B, Stockholm, Sweden, 131 30.
You can get more information about it from ALPHAHELIX MOL.DIAGN. SK1's website at https://levelbio.se.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4MB:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
